Switzerland – Reports of suspected adverse reactions to the COVID-19 vaccines in Switzerland – Update

To date, 63 side effect reports in connection with COVID-19 vaccinations in Switzerland have been evaluated

As at 4 February 2021, Swissmedic, in collaboration with the regional pharmacovigilance centres, has evaluated 63 reports of suspected adverse drug reactions (ADR) to COVID-19 vaccinations in Switzerland. So far there is no evidence of new safety signals.

As at 4 February 2021, a total of 63 reports of suspected adverse drug reactions (ADR) in connection with the COVID-19 vaccinations in Switzerland have been evaluated and assessed at Swissmedic.

Of those patients affected, there were more women (57%) than men (32%), although the gender is not stated in some reports (11%).

37 reports (59%) were classified as not serious. The most commonly reported reactions in these non-serious reports were headache, chills, fever and pain at the injection site…